PGHL2024-10-012024-12-31 PGHL2024-10-012024-12-31 PGHL2024-10-012024-12-31in-bse-fin:OneOperatingExpenses01Member PGHL2024-10-012024-12-31in-bse-fin:FourOperatingExpenses01Member PGHL2024-12-31 iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 500126 PGHL PGHL Procter & Gamble Health Limited Equity 2024-07-01 2025-03-31 2025-02-12 2024-12-05 INR Lakhs Half yearly 10:10:00 14:25:00 2025-01-11 2025-02-12 true Cash Flow Indirect Not applicable Single segment PHARMACEUTICALS 2024-10-01 2024-12-31 Unaudited Standalone 3097700000.00 39600000.00 3137300000.00 616000000.00 132800000.00 8500000.00 470500000.00 1500000.00 55500000.00 635600000.00 1920400000.00 1216900000.00 0.00 1216900000.00 290400000.00 17500000.00 307900000.00 0.00 909000000.00 0.00 0.00 0.00 0.00 909000000.00 -19900000.00 889100000.00 0.00 0.00 166000000.00 10 54.76 54.76 0.00 0.00 54.76 54.76 0.00 0.00 0.00 1)The above unaudited results have been reviewed by Audit Committee and approved by the Board of Directors of the Company at meeting held on 12th February, 2025. The statutory auditors of the Company have carried out limited review of the above unaudited financial results and have issued an unmodified limited review report. 2)Results for all above period have been prepared in accordance with Indian Accounting Standards ( Ind AS ) as prescribed under section 133 of the Companies Act, 2013 read with Companies (Indian Accounting Standard) Rules, 2015, as amended. 3)The Board of Directors, on 23rd January, 2025, approved the change of the Financial Year ending of the Company from June 30 to March 31. Accordingly, the current Financial Year of the Company viz., 2024-25 shall be a period of nine months commencing on 01st July, 2024, and ending on 31st March, 2025. 4)During the previous year, the Company discontinued production of injections at its manufacturing plant in Goa effective 30th September, 2023, as the Company started to source injections portfolio of its products from a contract manufacturer. Post evaluation of various alternatives, during the quarter ended 30th June, 2024 the Company entered into an agreement for sale of the assets of its injection plant for a consideration of Rs. 790 Lakhs and impaired the balance amount of Rs. 627 Lakhs. Based on above, the company had re-evaluated the usability of assets in their capital work in progress and thereby impaired other related assets by an amount of Rs. 1,392 Lakhs. The above total amount of Rs. 2,019 Lakhs have been disclosed as an exceptional item for the quarter and the year ended June 30, 2024. A portion of asset, pending disposal is reflected under Assets held for Sale in the balance sheet as at 31st December, 2024. 5)The Company has identified Pharmaceuticals as its single primary reportable segment in accordance with the requirement of Ind AS 108 - Operating Segments. Accordingly no separate segment information has been provided. 6)The Board of Directors at its meeting held on 12th February, 2025 have declared for the current year an interim dividend of Rs.80 per equity share of face value Rs.10 each aggregating to Rs.13,280 lakhs. 7)The Company does not have a subsidiary, an associate or a joint venture as at 31st December, 2024. 8)The unaudited financial results are available on the website of the Company (www.pghealthindia.com) and on the websites of BSE (www.bseindia.com) and NSE (www.nseindia.com). 9)Figures for earlier periods have been regrouped, wherever necessary. Single segment 2024-07-01 2024-12-31 Unaudited Standalone 6231800000.00 72400000.00 6304200000.00 1097700000.00 334400000.00 205700000.00 932700000.00 3000000.00 113200000.00 1286600000.00 3973300000.00 2330900000.00 0.00 2330900000.00 569900000.00 28700000.00 598600000.00 0.00 1732300000.00 0.00 0.00 0.00 0.00 1732300000.00 -18200000.00 1714100000.00 0.00 0.00 166000000.00 10 104.36 104.36 0.00 0.00 104.36 104.36 0.00 0.00 0.00 Other Expenses 635600000.00 Other Expenses 1286600000.00 1101600000.00 80400000.00 17300000.00 0.00 79100000.00 0.00 0.00 0.00 0.00 94400000.00 48500000.00 142900000.00 314300000.00 841000000.00 2576600000.00 1187800000.00 0.00 1306700000.00 2664300000.00 62900000.00 15700000.00 195400000.00 4245000000.00 0.00 681100000.00 6113900000.00 11000000.00 0.00 8701500000.00 166000000.00 5938600000.00 6104600000.00 6104600000.00 0.00 0.00 0.00 0.00 325600000.00 0.00 0.00 72100000.00 397700000.00 0.00 1714300000.00 209700000.00 1924000000.00 120400000.00 51200000.00 103600000.00 0.00 2199200000.00 0.00 0.00 2596900000.00 8701500000.00 3000000.00 -96700000.00 -433500000.00 -19400000.00 0.00 0.00 0.00 -114800000.00 0.00 36600000.00 0.00 -92700000.00 0.00 113200000.00 0.00 0.00 0.00 4300000.00 0.00 -300000.00 0.00 51500000.00 4100000.00 0.00 0.00 0.00 -20100000.00 300000.00 0.00 -667500000.00 1663400000.00 0.00 0.00 0.00 468700000.00 0.00 1194700000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 79000000.00 53300000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 50600000.00 0.00 20100000.00 0.00 96400000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 996000000.00 0.00 0.00 -15600000.00 -1011600000.00 279500000.00 0.00 279500000.00 2387300000.00 2666800000.00 -26600000.00 -24300000.00 -6700000.00 -6100000.00 0.00 0.00